
PANews reported on July 31st that Tether International Limited (TIL) today released its Q2 2025 attestation report, according to its official blog. The report shows that USDT issuance exceeded $13.4 billion in Q2 2025, bringing its circulating supply to over $157 billion (a $20 billion increase year-to-date). By the end of the second quarter, Tether's total holdings of U.S. Treasuries had exceeded $127 billion, an increase of approximately $8 billion from the first quarter, making it one of the world's largest holders of U.S. Treasuries. Meanwhile, shareholder capital in the company managing the reserve assets remained stable at approximately $5.47 billion compared to the previous quarter. Tether's net profit in the second quarter totaled approximately $4.9 billion, bringing its total net profit for the first half of the year to $5.7 billion. Year-to-date, TIL's recurring profit was $3.1 billion, excluding the market value contribution of gold and Bitcoin (which increased by $2.6 billion). As of June 30, 2025, the company's total assets are at least $162,574,933,798; the company's total liabilities are $157,108,009,474, of which $157,100,255,857 is related to the issued digital tokens; the company's assets exceed its liabilities; the company's proprietary investments in emerging fields such as artificial intelligence, renewable energy, and communications infrastructure through Tether Investments are not included in the reserves of the issued tokens.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.